Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 8/20 | 0.45 |
| ▸ | GSK3B | P49841 | 7/20 | 0.45 |
| ▸ | CLK4 | Q9HAZ1 | 6/20 | 0.45 |
| ▸ | PRKG1 | Q13976 | 6/20 | 0.45 |
| ▸ | GSK3A | P49840 | 6/20 | 0.45 |
| ▸ | ROCK2 | O75116 | 6/20 | 0.45 |
| ▸ | AURKB | Q96GD4 | 7/20 | 0.40 |
| ▸ | PKN2 | Q16513 | 6/20 | 0.40 |
| ▸ | CHEK2 | O96017 | 6/20 | 0.40 |
| ▸ | PRKACA | P17612 | 6/20 | 0.40 |
| ▸ | RPS6KA3 | P51812 | 6/20 | 0.40 |
| ▸ | CDC42BPA | Q5VT25 | 6/20 | 0.40 |
| ▸ | NEK4 | P51957 | 5/20 | 0.40 |
| ▸ | RPS6KB1 | P23443 | 5/20 | 0.40 |
| ▸ | HIPK4 | Q8NE63 | 5/20 | 0.40 |
| ▸ | PRKCD | Q05655 | 5/20 | 0.40 |
| ▸ | CSNK1G3 | Q9Y6M4 | 4/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 4/20 | 0.40 |
| ▸ | MKNK2 | Q9HBH9 | 4/20 | 0.40 |
| ▸ | SGK2 | Q9HBY8 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4905370 | 0.90 | ROCK1 (0.46) | ROCK1GSK3BCLK4PRKG1GSK3A | |
| SCHEMBL4897232 | 0.89 | ROCK2 (0.44) | ROCK1GSK3BCLK4PRKG1GSK3A | |
| SCHEMBL4897323 | 0.88 | GSK3B (0.48) | ROCK1GSK3BCLK4PRKG1GSK3A | |
| SCHEMBL4908343 | 0.86 | ROCK1 (0.46) | ROCK1GSK3BCLK4PRKG1GSK3A | |
| SCHEMBL4910893 | 0.85 | ROCK1 (0.47) | ROCK1GSK3BCLK4PRKG1GSK3A | |
| SCHEMBL4598260 | 0.83 | ROCK1 (0.47) | ROCK1GSK3BCLK4PRKG1GSK3A | |
| SCHEMBL14066718 | 0.83 | MAPKAPK2 (0.54) | ROCK1GSK3BCLK4PRKG1GSK3A | |
| SCHEMBL4897729 | 0.83 | TNNI3K (0.33) | CDK1CDK2KDRIP6K1QPCT | |
| SCHEMBL4904962 | 0.82 | GSK3B (0.47) | ROCK1GSK3BCLK4PRKG1GSK3A | |
| SCHEMBL4900176 | 0.82 | ALOX5AP (0.40) | ROCK1GSK3BCLK4PRKG1GSK3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080234266-A1 | Squaric Acid Derivatives II | MERCK PATENT GESELLSCHAFT (DE) | 2008-09-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234266-A1 | Squaric Acid Derivatives II | CHEK2, CHEK1, SGK3 | ROCK1 713/4885GSK3B 132/4885CLK4 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.